Your browser doesn't support javascript.
loading
Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.
Lee, Bruce Y; Brown, Shawn T; Haidari, Leila A; Clark, Samantha; Abimbola, Taiwo; Pallas, Sarah E; Wallace, Aaron S; Mitgang, Elizabeth A; Leonard, Jim; Bartsch, Sarah M; Yemeke, Tatenda T; Zenkov, Eli; Ozawa, Sachiko.
Afiliación
  • Lee BY; Public Health Computational and Operations Research (PHICOR), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Global Obesity Prevention Center (GOPC), Joh
  • Brown ST; Pittsburgh Supercomputing Center (PSC), Carnegie Mellon University, Pittsburgh, PA, United States; McGill Centre for Integrative Neuroscience, McGill Neurological Institute, McGill University, Montreal, Canada.
  • Haidari LA; Pittsburgh Supercomputing Center (PSC), Carnegie Mellon University, Pittsburgh, PA, United States.
  • Clark S; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, United States.
  • Abimbola T; Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.
  • Pallas SE; Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.
  • Wallace AS; Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.
  • Mitgang EA; Public Health Computational and Operations Research (PHICOR), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Global Obesity Prevention Center (GOPC), Joh
  • Leonard J; Pittsburgh Supercomputing Center (PSC), Carnegie Mellon University, Pittsburgh, PA, United States.
  • Bartsch SM; Public Health Computational and Operations Research (PHICOR), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Global Obesity Prevention Center (GOPC), Joh
  • Yemeke TT; Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, NC, United States.
  • Zenkov E; Pittsburgh Supercomputing Center (PSC), Carnegie Mellon University, Pittsburgh, PA, United States.
  • Ozawa S; Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina - Chapel Hill, Chapel Hill, NC, United States; Department of Maternal and Child Health, UNC Gillings School of Global Public Health, University of North Carolina - Chapel Hill, Chap
Vaccine ; 37(17): 2377-2386, 2019 04 17.
Article en En | MEDLINE | ID: mdl-30922700
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Factores de Riesgo / Análisis Costo-Beneficio / Sarampión Tipo de estudio: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Factores de Riesgo / Análisis Costo-Beneficio / Sarampión Tipo de estudio: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos